Skip to content

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial: The AIM Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04909593
Acronym
AIM
Enrollment
21
Registered
2021-06-02
Start date
2021-05-24
Completion date
2022-11-22
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Intractable Pain, Low Back Pain, Pain, Back, Pain, Neuropathic

Brief summary

The purpose of the study is to assess the feasibility of using information extracted from physiologic signals to automatically adjust stimulation in patients undergoing Spinal Cord Stimulation (SCS).

Interventions

DEVICESpinal Cord Stimulation

Spinal cord stimulation at varied electrode, pulse width, frequency and amplitude parameters

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Study candidate is undergoing a temporary SCS trial of commercially approved BSC neurostimulator system, per local directions for use (DFU). * Subject signed a valid, EC/IRB-approved informed consent form. * Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law when written informed consent is obtained. * In the clinician best judgment, subject is able to distinguishably describe quality and location of sensation and pain. Key

Exclusion criteria

* Subject meets any contraindication in BSC neurostimulation system local DFU. * Investigator-suspected gross lead migration during the SCS trial period which may preclude the study candidate from receiving adequate SCS therapy. * Subject is currently diagnosed with cognitive impairment, or exhibits any characteristic, that in the clinician's best judgement would limit study candidate's ability to assess and report sensation information. * Subject is currently diagnosed with a physical impairment, or exhibits a condition that would limit study candidate's ability to complete study assessments.

Design outcomes

Primary

MeasureTime frameDescription
Perception ThresholdProgramming Visit (up to 15 days post-screening)Percent change in patient's perceiving spinal cord stimulation (i.e. Perception Threshold) when going from a reclining to sitting position in a reclining chair

Countries

United States

Participant flow

Participants by arm

ArmCount
Spinal Cord Stimulation
SCS trial systems including external trial stimulators, lead(s)/extensions(s), and operating room (OR) cable(s)/extender(s) and optional sensor. Spinal Cord Stimulation: Spinal cord stimulation at varied electrode, pulse width, frequency and amplitude parameters
21
Total21

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicSpinal Cord Stimulation
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
1 Participants
Race/Ethnicity, Customized
Black, of African Heritage
2 Participants
Race/Ethnicity, Customized
Caucasian
17 Participants
Race/Ethnicity, Customized
Native American
1 Participants
Region of Enrollment
United States
21 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

Perception Threshold

Percent change in patient's perceiving spinal cord stimulation (i.e. Perception Threshold) when going from a reclining to sitting position in a reclining chair

Time frame: Programming Visit (up to 15 days post-screening)

Population: Subjects who received programming with SCS trial neurostimulator system.

ArmMeasureValue (MEAN)Dispersion
Spinal Cord StimulationPerception Threshold157 percent change in perception thresholdStandard Deviation 52

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026